Search
Now showing items 1-4 of 4
Studies on syndecan-1 in mesenchymal tumors
(2010-01-08)
The syndecans are a four-member family of type I transmembrane proteoglycans. Their core proteins have a short cytoplasmic domain, a transmembrane domain and a large N-terminal extracellular domain possessing glycosaminoglycan ...
Follicular lymphoma : clinical and biological factors associated with response to therapy and overall prognosis
(2020-01-29)
Follicular lymphoma (FL) is a heterogeneous group of malignancies within the adaptive immune system. The clinical course is highly variable. Treatment includes different chemotherapy regimens as well as the anti-CD20 ...
Prognostic information from nonmalignant and malignant lymphocytes in follicular lymphoma in relation to therapy
(2011-04-19)
Follicular lymphoma is the most common indolent lymphoma. It is composed of centrocytes and centroblasts, residing in follicles that also harbour nonmalignant immune and stroma cells. Follicular lymphoma is graded according ...
Role of syndecan-1 in tumor cell proliferation and epithelial-mesenchymal plasticity
(2020-10-15)
Syndecan-1 (SDC1) is a heparan sulfate proteoglycan (HSPG) intercalated in the cell membrane but also translocated to the cell nucleus in a regulated manner. SDC1 is involved in several malignancy-associated processes such ...